Search

Displaying results 8781 - 8790 of 10000 in total
  1. Drug

    GLB-005

    go.drugbank.com/drugs/DB32797
    Experimental

    GLB-005 is a molecular glue degrader targeting WIZ and is being investigated for treatment of sickle cell disease and β-thalassemia.[L56125, L56126, L56128]

  2. Drug

    GLB-007

    go.drugbank.com/drugs/DB32798
    Experimental

    GLB-007 is a molecular glue degrader targeting WIZ and ZBTB7A.[L56125, L56126, L56128]

  3. Drug

    GLB-006

    go.drugbank.com/drugs/DB32799
    Experimental

    GLB-006 is a molecular glue degrader targeting NEK7.[L56125, L56126]

  4. Drug

    APT20TTMG

    go.drugbank.com/drugs/DB32869
    Experimental

    APT20TTMG is a synthetic DNA that modulates U1 small nuclear ribonucleoprotein misassembly.

  5. Drug

    RS5441

    go.drugbank.com/drugs/DB33178
    Experimental

    RS5441, also known as ET-02, is a small molecule topical medication investigated for male pattern baldness and age-related alopecia.[L57508, L57509]

  6. Drug

    Enlimomab

    go.drugbank.com/drugs/DB33731
    Experimental

    Categories: Intercellular Adhesion Molecule-1
  7. Drug

    GenSci148

    go.drugbank.com/drugs/DB33957
    Experimental

    GenSci148 is a biologic drug. … GenSci148 is under investigation in clinical trial NCT07817615 (A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal

  8. Drug

    ATTO-1091

    go.drugbank.com/drugs/DB33956
    Experimental

    ATTO-1091 is a biologic drug.

  9. Drug

    REC-7735

    go.drugbank.com/drugs/DB33958
    Experimental

    REC-7735 is a small molecule drug. REC-7735 is under investigation in clinical trial NCT07819136 (REC-7735 in Participants With Solid Tumors).

  10. Drug

    SZN-8141

    go.drugbank.com/drugs/DB33960
    Experimental

    SZN-8141 is a biologic drug. SZN-8141 is under investigation in clinical trial NCT07817121 (A First-in-human Trial of SZN-8141 in Diabetic Macular Edema).